Effects of sinus rhythm maintenance on left heart function after electrical cardioversion of atrial fibrillation: Implications for tachycardia-induced Cardiomyopathy

Canadian Journal of Cardiology

Volumn 31, Issue 1, 2015, Pages 36-43

  Zimmermann, Andreas J ^a   Bossard, Matthias ^a   Aeschbacher, Stefanie ^a   Schoen, Tobias ^a   Voellmin, Gian ^a   Suter, Yves ^a   Lehmann, Anouk ^a   Hochgruber, Thomas ^a   Pumpol, Katrin ^a   Sticherling, Christian ^a   Kühne, Michael ^a   Conen, David ^a   Kaufmann, Beat A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIAC PATIENT; CARDIOVERSION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; RELAPSE; SINUS RHYTHM; TACHYCARDIA INDUCED CARDIOMYOPATHY; THREE DIMENSIONAL IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; COMPLICATION; CONVALESCENCE; FOLLOW UP; HEART MUSCLE CONDUCTION SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TIME; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84920369293     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.10.032     Document Type: Article

References (35)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
2. Conen D., Chae C.U., Glynn R.J., et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011, 305:2080-2087.
3. Anderson J.L., Halperin J.L., Albert N.M., et al. Management of patients with atrial fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2013, 61:1935-1944.
4. Ionescu-Ittu R., Abrahamowicz M., Jackevicius C.A., et al. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med 2012, 172:997-1004.
5. Raymond R.J., Lee A.J., Messineo F.C., Manning W.J., Silverman D.I. Cardiac performance early after cardioversion from atrial fibrillation. Am Heart J 1998, 136:435-442.
6. Deedwania P.C., Lardizabal J.A. Atrial fibrillation in heart failure: a comprehensive review. Am J Med 2010, 123:198-204.
7. Suman-Horduna I., Roy D., Frasure-Smith N., et al. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. JAm Coll Cardiol 2013, 61:455-460.
8. Shinbane J.S., Wood M.A., Jensen D.N., et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. JAm Coll Cardiol 1997, 29:709-715.
9. Umana E., Solares C.A., Alpert M.A. Tachycardia-induced cardiomyopathy. Am J Med 2003, 114:51-55.
10. Nerheim P., Birger-Botkin S., Piracha L., Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004, 110:247-252.
11. Calvo N., Bisbal F., Guiu E., et al. Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation. Int J Cardiol 2013, 168:4093-4097.
12. Welikovitch L., Lafreniere G., Burggraf G.W., Sanfilippo A.J. Change in atrial volume following restoration of sinus rhythm in patients with atrial fibrillation: a prospective echocardiographic study. Can J Cardiol 1994, 10:993-996.
13. Xiong C., Sonnhag C., Nylander E., Wranne B. Atrial and ventricular function after cardioversion of atrial fibrillation. Br Heart J 1995, 74:254-260.
14. Upshaw C.B. Hemodynamic changes after cardioversion of chronic atrial fibrillation. Arch Intern Med 1997, 157:1070-1076.
15. Clark D.M., Plumb V.J., Epstein A.E., Kay G.N. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. JAm Coll Cardiol 1997, 30:1039-1045.
16. Viswanathan K., Daniak S.M., Salomone K., et al. Effect of cardioversion of atrial fibrillation on improvement in left ventricular performance. Am J Cardiol 2001, 88:439-441.
17. Therkelsen S.K., Groenning B.A., Svendsen J.H., Jensen G.B. Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol 2006, 97:1213-1219.
18. Spinale F.G., Tomita M., Zellner J.L., et al. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol 1991, 261:H308-H318.
19. Perreault C.L., Shannon R.P., Komamura K., Vatner S.F., Morgan J.P. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. JClin Invest 1992, 89:932-938.
20. Yamamoto K., Burnett J.C., Meyer L.M., et al. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol 1996, 271:R1529-R1534.
21. Spinale F.G., Tanaka R., Crawford F.A., Zile M.R. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992, 85:717-729.
22. Shannon R.P., Komamura K., Shen Y.T., Bishop S.P., Vatner S.F. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol 1993, 265:H801-H809.
23. Rohner A., Brinkert M., Kawel N., et al. Functional assessment of the left atrium by real-time three-dimensional echocardiography using a novel dedicated analysis tool: initial validation studies in comparison with computed tomography. Eur J Echocardiogr 2011, 12:497-505.
24. Buechel R.R., Sommer G., Leibundgut G., et al. Assessment of left atrial functional parameters using a novel dedicated analysis tool for real-time three-dimensional echocardiography: validation in comparison to magnetic resonance imaging. Int J Cardiovasc Imaging 2013, 29:601-608.
25. Gosselink A.T., Blanksma P.K., Crijns H.J., et al. Left ventricular beat-to-beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals. JAm Coll Cardiol 1995, 26:1516-1521.
26. Wozakowska-Kaplon B., Opolski G. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Int J Cardiol 2004, 96:171-176.
27. Spinale F.G., Zellner J.L., Tomita M., Crawford F.A., Zile M.R. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res 1991, 69:1058-1067.
28. Emilsson K., Wandt B. The relation between ejection fraction and mitral annulus motion before and after direct-current electrical cardioversion. Clin Physiol 2000, 20:218-224.
29. Nishino M., Hoshida S., Tanouchi J., et al. Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol 2000, 85:1451-1454.
30. Corley S.D., Epstein A.E., DiMarco J.P., et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109:1509-1513.
31. Mattioli A.V., Bonatti S., Bonetti L., Mattioli G. Left atrial size after cardioversion for atrial fibrillation: effect of external direct current shock. JAm Soc Echocardiogr 2003, 16:271-276.
32. Khan I.A. Atrial stunning: basics and clinical considerations. Int J Cardiol 2003, 92:113-128.
33. Flaker G., Lopes R.D., Al-Khatib S.M., et al. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). JAm Coll Cardiol 2014, 63:1082-1087.
34. Mor-Avi V., Sugeng L., Lang R.M. Real-time 3-dimensional echocardiography: an integral component of the routine echocardiographic examination in adult patients?. Circulation 2009, 119:314-329.
35. Thavendiranathan P., Liu S., Verhaert D., et al. Feasibility, accuracy, and reproducibility of real-time full-volume 3D transthoracic echocardiography to measure LV volumes and systolic function: a fully automated endocardial contouring algorithm in sinus rhythm and atrial fibrillation. JACC Cardiovasc Imaging 2012, 5:239-251.